Evidence map›Paper›PMID 35967133›Full record

ArticleCureus2022

Isolated Pyridoxine Deficiency Presenting as Peripheral Neuropathy Post-chemotherapy.

Aanchal Sawhney, Sachi Singhal, Rahul Patel

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Aanchal SawhneyInternal Medicine, Crozer-Chester Medical Center, Upland, USA.
Sachi SinghalInternal Medicine, Crozer-Chester Medical Center, Upland, USA.
Rahul PatelInternal Medicine, Crozer-Chester Medical Center, Upland, USA.
Crozer-Keystone Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyridoxine deficiency is a rare but identifiable cause of sideroblastic anemia, depression, and peripheral neuropathy. Platinum-based chemotherapeutic drugs display structural similarity to pyridoxine, which interferes with the absorption and hence the efficacy of the drug. If left untreated, it can lead to irreversible axonal loss and permanent deficits, leading to falls. Our case is a highly unusual scenario of isolated pyridoxine deficiency presenting as peripheral neuropathy and depression as a delayed side effect of chemotherapeutic drugs.

Indexed as

carboplatin-etoposidechemotherapy-induced polyneuropathyperipheral neuropathypyridoxal kinasepyridoxine deficiency

Identifiers

PMID35967133
PMCPMC9363682
OpenAlexW4285013814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.